MENU
+Compare
CRSP
Stock ticker: NASDAQ
AS OF
Aug 1 closing price
Price
$56.09
Change
-$0.17 (-0.30%)
Capitalization
4.84B

CRSP CRISPR Therapeutics AG Forecast, Technical & Fundamental Analysis

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CRSP with price predictions
Jul 31, 2025

CRSP in +4.30% Uptrend, advancing for three consecutive days on July 23, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CRSP advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 50-day moving average for CRSP moved above the 200-day moving average on July 18, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 170 cases where CRSP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CRSP moved out of overbought territory on July 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for CRSP turned negative on July 29, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRSP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CRSP broke above its upper Bollinger Band on July 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRSP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.648) is normal, around the industry mean (17.805). P/E Ratio (0.000) is within average values for comparable stocks, (61.184). CRSP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.615). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (136.986) is also within normal values, averaging (276.801).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRSP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CRSP is expected to report earnings to fall 11.39% to -139 cents per share on August 11

CRISPR Therapeutics AG CRSP Stock Earnings Reports
Q2'25
Est.
$-1.40
Q1'25
Missed
by $0.37
Q4'24
Beat
by $0.79
Q3'24
Beat
by $0.37
Q2'24
Missed
by $0.06
The last earnings report on May 06 showed earnings per share of -158 cents, missing the estimate of -121 cents. With 2.99M shares outstanding, the current market capitalization sits at 4.84B.
A.I. Advisor
published General Information

General Information

a developer of gene-based medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Baarerstrasse 14
Phone
+41 415613277
Employees
407
Web
https://www.crisprtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGSEX73.26N/A
N/A
AMG Veritas Asia Pacific N
MSSGX17.05N/A
N/A
Morgan Stanley Inst Inception I
FWIFX37.57N/A
N/A
Fidelity Advisor Worldwide I
STAFX44.82N/A
N/A
Allspring Large Cap Growth A
APHKX52.23-0.52
-0.99%
Artisan International Value Instl

CRSP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-2.46%
RXRX - CRSP
70%
Closely correlated
-0.17%
BEAM - CRSP
70%
Closely correlated
-2.23%
NTLA - CRSP
65%
Loosely correlated
-5.60%
CRBU - CRSP
63%
Loosely correlated
-0.98%
ABCL - CRSP
62%
Loosely correlated
-2.19%
More

Groups containing CRSP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-2.46%
CRSP
(4 stocks)
94%
Closely correlated
-2.65%